Related Experiment Video
Updated: Jul 12, 2026
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
[Scanning of drug targets related to uterus contraction from the uterine smooth muscles by cDNA microarray]
Wei-She Zhang1, Qing-Hua Liang, Qing-Sheng Xie
1Department of Obstetrics and Gynecology, Xiangya Hospital, Central South University, Changsha 410008, China.
Objective:
To screen the differentially expressed gene profile from the smooth muscles in the fundus uterus at the active stage of labor, and to provide candidate genes for picking out the drug targets related to uterine contraction.
Methods:
Differentially expressed genes of uterine smooth muscles in the corpus from pro and post spontaneous parturition and those induced by oxytocin,as well as those from the corpus and the lower portion spontaneous parturition,were scanned respectively by human full-length genetic cDNA microarray with 8064 probe sets. Semi-quantitative RT-PCR was applied to testify the expression of voltage dependent calcium channel-L subtype (CACNA). The differentially expressed genes in the structure and function of the drug targets were picked out by bio-informatics to serve as candidate drug targets related to uterine contraction.
Results:
The expressions of 29 genes were upregulated in fundus smooth muscles from the pro and post natural parturition, the pro and post inductive parturition of oxytocin, and the natural parturition. The expression of CACNA gene in RT-PCR was in accordance with that in the microarray. Among the 29 genes, neuromedin B receptor (NMBR) gene and neuropeptide Y (NPY) gene were the genes which not only had the targets of uterine contracted medicine, but also could contract the uterine. The differential expression ratios of NMBR in the above 3 types of uterine myometrium were 6.9,11.3, and 9.0, respectively while those of NPY were 6.0,29.8, and 2.9 respectively.
Conclusion:
NMBR, whose expression in the uterine smooth muscles is always up-regulated at different parturition conditions, is likely to be an ideal candidate target of uterotonic drugs.
Insights
Neuromedin B receptor (NMBR) gene expression increases in uterine smooth muscle during labor. This finding identifies NMBR as a potential target for drugs that enhance uterine contractions.
Area of Science:
- Reproductive biology and molecular genetics.
- Uterine physiology and pharmacology.
Context:
- Uterine smooth muscle plays a critical role in labor and delivery.
- Identifying molecular targets for modulating uterine contraction is crucial for managing labor complications.
Purpose:
- To identify differentially expressed genes in uterine smooth muscle during active labor.
- To find candidate genes for developing novel uterotonic drugs.
Summary:
- A human cDNA microarray screened 8064 genes in uterine smooth muscle under various labor conditions.
- Neuromedin B receptor (NMBR) and neuropeptide Y (NPY) genes showed significant upregulation.
- NMBR expression was consistently elevated across different labor scenarios, suggesting its role in uterine contraction.
Impact:
- NMBR is proposed as a key molecular target for developing new drugs to manage uterine contraction.
- This research provides a foundation for targeted pharmacological interventions in obstetrics.
More Related Videos
06:22Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
Published on: September 1, 2019
10:24A High Throughput in situ Hybridization Method to Characterize mRNA Expression Patterns in the Fetal Mouse Lower Urogenital Tract
Published on: August 19, 2011